Gustavo Turecki, MD, PhD
- 14Articles
- 97.9KReads
- 2006–2020Active
- 94Collaborators
- 484Citations
About
Gustavo Turecki, MD, PhD, is affiliated with the Douglas Institute and the Department of Psychiatry at McGill University in Montreal, Quebec, Canada. His published work from 2006 to 2020 focuses on suicide and major depressive disorder, including studies on antidepressant treatment responses, suicidal behavior risk factors, and the safety of pharmacological interventions. He has contributed to research on clinical predictors of suicidal ideation, the efficacy of drug augmentations in depression, and the association between personality disorders and suicidal behavior.
Publications
Worsening of Suicidal Ideation During AD Treatment
May 7, 2019
CAN-BIND-1 Outcomes and Early Response Prediction in MDD
February 5, 2019
Attempted Suicide Among Students and Young Adults in Montreal, Quebec, Canada: A Retrospective Cross-Sectional Study of Hospitalized and Nonhospitalized Suicide Attempts Based on Chart Review
October 29, 2015
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
